| Literature DB >> 31880266 |
Jicheng Wang1,2, Shizhang Liu1, Jiyuan Shi1, Huitong Liu1, Jingyuan Li1, Song Zhao1,2, Zhi Yi1.
Abstract
Bone Marrow Mesenchymal Stem Cells (BMSCs) are one of the primary cells found in the bone marrow, and they can differentiate into osteoblasts, chondrocytes, adipocytes and even myoblasts, and are, therefore, considered pluripotent cells. Because of their multipotential differentiation, selfrenewal capability, immunomodulation and other potential activities, BMSCs have become an important source of seed cells for gene therapy, tissue engineering, cell replacement therapy and regenerative medicine. Long non-coding RNA (lncRNA) is an RNA molecule greater than 200 nucleotides in length that is expressed in a variety of species, including animals, plants, yeast, prokaryotes, and viruses, but lacks an apparent open reading frame, and does not have the function of translation into proteins. Many studies have shown that lncRNAs play an important role in the osteogenic differentiation of BMSCs. Here, we describe the role of lncRNAs in the osteogenic differentiation of BMSCs, in order to provide a new theoretical and experimental basis for bone tissue engineering and clinical treatment. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.Entities:
Keywords: Bone marrow mesenchymal stem cells (BMSCs); bone defects; bone regeneration; bone tissue engineering; long noncoding RNAs (lncRNAs); osteogenic differentiation; treatment.
Year: 2020 PMID: 31880266 DOI: 10.2174/1574888X15666191227113742
Source DB: PubMed Journal: Curr Stem Cell Res Ther ISSN: 1574-888X Impact factor: 3.828